ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TTI Thiogenesis Therapeutics Corp

0.59
0.00 (0.00%)
27 Dec 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 2019202020212021202220222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 0000000
Operating Income 0-31k0-1.39M-3k-3.61M-4.72M
Pre Tax Income -8k-128k-93k-1.22M-224k-3.92M-5.03M
Net Income -8k-128k-93k-1.22M-224k-3.92M-5.03M
Preferred Dividends 0000000
Basic Earnings Per Share (EPS) -0.003-0.028-0.021-0.102-0.048-0.101-0.113
EBIT 0-31k0-1M-3k-3.58M-4.72M
EBITDA 0-31k0-1.39M-3k-3.61M-4.72M

Your Recent History

Delayed Upgrade Clock